🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Belgium / NCT06931795
Starting soon Not applicable

Implementation of a HABIT-ILE Intervention at William Lennox Neurological Hospital (NeuREHA) - Adult

NCT06931795 · tracked via the Priya Life Science Belgium tracker
Phase
Not applicable
Started
2025-04-15
Last updated
2025-04-17

Condition(s) studied

Stroke

Investigational drug(s) / intervention(s)

HABIT-ILEConventional intervention

HABIT-ILE: 2 weeks HABIT-ILE

Conventional intervention: 2 weeks usual intervention (waitlist group)

Study summary

Using a randomized controlled trial design, in an hospital environment, possible changes induced by the "Hand-arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE)" treatment program will be investigated in functional activities of daily living, motor and cognitive assessment of patients with sub-acute post-stroke

Eligibility

Sex
ALL
Min age
18 Years
Max age
95 Years
Healthy volunteers
No
Inclusion Criteria: * Phase aiguë ou subaiguë Exclusion Criteria: * Epilepsie instable * Absence à déterminer sa volonté à participer * Traitement toxine pendant le stage

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Institute of Neurosciences, UCLouvain Brussels Belgium
Institute of Neurosciences, UCLouvain Brussels Belgium
Spontaneous contact via doctors or other partners Brussels Belgium

More Université Catholique de Louvain trials in Belgium

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06931795 on ClinicalTrials.gov ↗ ← All trials in Belgium